Physician profile
Robert A Brooks
NPI 1790791838
$2,582.58
in general payments reported to CMS, 2019-2025
22 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $471 · 2022: $137 · 2023: $1,481 · 2024: $206 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045 · Travel and Lodging: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.38 |
| Travel and Lodging | $928.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,132.48 | 2023-2024 | Ribfix Blu Advantage, Advantagerib, Gel-One Cross-Linked Hyaluronate |
| Organogenesis INC. | $549.09 | 2021-2023 | Puraply |
| Regeneron Healthcare Solutions, INC. | $156.25 | 2023-2025 | Libtayo |
| Medtronic, INC. | $132.87 | 2021-2025 | Maxtack |
| Merck Sharp & Dohme LLC | $86.42 | 2024-2025 | Keytruda, Lynparza |
| Mauna Kea Technologies, INC. | $71.71 | 2023 | |
| Davol INC. | $70.31 | 2021-2025 | Phasix Mesh |
| Boston Scientific Corporation | $68.04 | 2021-2024 | Varithena Administration Pack |
| Hologic Sales and Service, LLC | $39.69 | 2024-2025 | Magtrace, Coolseal Generator |
| Astrazeneca Pharmaceuticals LP | $32.35 | 2024 | Andexxa |
| Kci USA, INC. | $31.07 | 2021 | |
| Csl Behring | $25.61 | 2023 | Kcentra |
| Pacira Pharmaceuticals Incorporated | $25.06 | 2025 | Exparel, Zilretta |
| Heron Therapeutics, INC. | $23.87 | 2024 | Aponvie |
| Sanara Medtech INC. | $22.50 | 2024 | Biasurge |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $20.65 | 2025 | Stimulan |
| Tela Bio, INC. | $19.64 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $17.89 | 2025 | Collagenase Santyl |
| Baudax Bio INC. | $16.99 | 2021 | |
| W. L. Gore & Associates, INC. | $13.76 | 2021 | |
| Ferring Pharmaceuticals INC. | $13.19 | 2021 | |
| Braintree Laboratories, INC. | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.